The Promiscuity of EpoC Towards Polymer Bound Substrates
The Promiscuity of EpoC Towards Polymer Bound Substrates
批准号:
7179269
负责人:
Zachary David Aron
金额:
$2.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-01-03 至 2007-05-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Small molecule peptide, polyketide and hybrid polyketide/polypeptide natural products are characterized by their potent biological activities and modular biosyntheses. These compounds typically are generated by modular polyketide synthase (PKS), nonribosomal peptide synthetase (NRPS) and hybrid NRPS/PKS enzymes. To date, there has been limited study of the NRPS/PKS interface of hybrid NRPS/PKS enzymes. This proposal seeks to examine the NRPS/PKS interface of epothilone synthase by exploring the promiscuity of the ketosynthase (KS) domain of epoC towards solid phase bound peptide substrates. EpoC, which sits at the hybrid NRPS/PKS interface of epothilone synthase, was chosen for this study because of the pharmaceutical significance of the epothilones and the extensive body of work regarding their biosynthesis. By applying this technology to libraries of peptide substrates a detailed understanding of the substrate specificity of epoC will be developed, opening the door to reengineering epothilone biosynthesis to generation of novel epothilone derivatives. Also, by fusing epoC to additional PKS modules, combinatorial libraries of hybrid polypeptide/polyketide molecules can be accessed for drug discovery by semibiosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a New Class of Hepatitis B Virus Inhibitors that Induce a Novel Defective Nucleocapsid Phenotype
-
批准号:10081385
-
项目类别:
-
资助金额:$29.85万
-
财政年份:2020
-
负责人:Zachary David Aron
-
依托单位:
Development of a New Class of Hepatitis B Virus Inhibitors that Induce a Novel Defective Nucleocapsid Phenotype
-
批准号:10220712
-
项目类别:
-
资助金额:$29.83万
-
财政年份:2020
-
负责人:Zachary David Aron
-
依托单位:
EF-Tu binding Tetrazoles targeting MDR Neisseria gonorrhoeae
-
批准号:9753119
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2018
-
负责人:Zachary David Aron
-
依托单位:
Oxadiazole Inhibitors of Non-Stop Ribosome Rescue to treat MDR Neisseria gonorrhoeae
-
批准号:9975690
-
项目类别:
-
资助金额:$105.81万
-
财政年份:2017
-
负责人:Zachary David Aron
-
依托单位:
Development of small molecule TLR5 inhibitors for rheumatoid arthritis therapy
-
批准号:9408815
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2017
-
负责人:Zachary David Aron
-
依托单位:
Novel beta-lactams as inhibitors of ebola virus infections
-
批准号:9303299
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2016
-
负责人:Zachary David Aron
-
依托单位:
Novel beta-lactams as inhibitors of ebola virus infections
-
批准号:9046014
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2016
-
负责人:Zachary David Aron
-
依托单位:
The Promiscuity of EpoC Towards Polymer Bound Substrates
-
批准号:6831756
-
项目类别:
-
资助金额:$4.11万
-
财政年份:2005
-
负责人:Zachary David Aron
-
依托单位:
The Promiscuity of EpoC Towards Polymer Bound Substrates
-
批准号:6984779
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2005
-
负责人:Zachary David Aron
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: